Skip to content
Medical Health Aged Care

Three distinguished Australian heart leaders elected to World Heart Federation Board

The Heart Foundation 2 mins read

Heart Foundation CEO David Lloyd has been elected as vice president-elect of the Board of the World Heart Federation, effective from January 2025.

Mr Lloyd is one of three Australians to be elected and will be joined by Professor Julie Redfern from Bond University and Tanya Hall, CEO and founder of patient advocacy group hearts4heart.

The full list of newly-elected members includes:

  • President-Elect: Dorairaj Prabhakaran (India)
  • Vice President-Elect: David Lloyd (Australia)
  • Treasurer: Rick Chazal (United States)

Members at Large:

  • Amitava Banerjee (United Kingdom)
  • Andréa Araujo Brandão (Brasil)
  • José Ramón González Juanatey (Spain)
  • Tanya Hall (Australia)
  • Elijah Ogola (Kenya)
  • Julie Redfern (Australia)

The elected Board Members will take office in January 2025, alongside four Strategic Partners, three Co-Opted Board Members, the Global Heart Editor, and the Chairs of the WHF Committees.

Comments attributable to David Lloyd, Heart Foundation CEO and vice president-elect to the World Heart Federation Board:

“I am very excited to be working alongside other leaders in the field, including Australia’s own Prof. Julie Redfern and Tanya Hall.”

Comments attributable to Professor Julie Redfern, Director & Research Professor, Institute for Evidence-Based Healthcare, Bond University:

"I have been supported by the National Heart Foundation and NHMRC for many years and have been involved with the World Heart Federation since being selected Emerging Leader in 2015.

“I am now thrilled to work with the new World Heart Federation Board as we pursue ‘cardiovascular health for everyone.’ It is wonderful to see Australians leading the way."

Comments attributable to Tanya Hall, CEO and Founder, hearts4heart:

“I look forward to collaborating with the distinguished World Heart Federation Board, fellow Australians David Lloyd and Julie Redfern, and contributing to the global fight against heart disease.”

 

 

About the World Heart Federation

A leader and convener in global cardiovascular health, the World Heart Federation champions heart health and acts to reduce the global burden of heart disease and stroke, which together claim 20.5 million lives every year.

The WHF’s membership of more than 200 heart foundations, scientific societies and patient organisations in more than 100 countries is an active hub, promoting heart health and driving change at the local, regional and global level.

As the principal representative body of the global cardiovascular community, WHF brings together a diverse network of multi-sectoral actors to share knowledge, guide policy, and give people the tools they need to live longer, healthier lives.


Key Facts:

Heart Foundation CEO David Lloyd has been elected as vice president-elect of the Board of the World Heart Federation, effective from January 2025.

Mr Lloyd is one of three Australians to be elected and will be joined by Professor Julie Redfern from Bond University and Tanya Hall, CEO and founder of patient advocacy group hearts4heart.


Contact details:

Media enquiries

Shaun Inguanzo, media manager, Heart Foundation

M: 0404 769 054 E: media@heartfoundation.org.au

More from this category

  • Disability, Medical Health Aged Care
  • 20/12/2024
  • 17:36
Kuremara

Kuremara to Open a State-of-the-Art Activity Center in Milton, QLD, in January 2025

Kuremara, a trusted and leading NDIS-registered provider in Australia, is excited to announce the opening of its newest facility—a cutting-edge activity center in Milton,…

  • Contains:
  • Legal, Medical Health Aged Care
  • 20/12/2024
  • 17:29
JGA Saddler

BREAKING NEWS: Australian law firm takes on Johnson & Johnson for selling Australians ineffective medicine

Vision available: Lawyer and doctor VNR, editorial photos and radio grabs included can be found in this SharePoint File In-person lawyer interviews available by…

  • Contains:
  • Medical Health Aged Care
  • 20/12/2024
  • 12:01
NDARC/UNSW

ADHD drug shows promise for treating methamphetamine dependence, landmark Australian study shows

A prescription medication used to treat attention deficit hyperactivity disorder (ADHD) could be repurposed as the first pharmacotherapy for people with methamphetamine dependence, according to a study published in Addiction. Results from the landmark ‘LiMA’ trial show that thepsychostimulant lisdexamfetamine can drastically reduce the need to use methamphetamine among those who are dependent on the illicit drug. Lead author and addiction medicine specialist Professor Nadine Ezard, who is Director of the National Centre for Clinical Research on Emerging Drugs (NCCRED), said the results were promising. "There is currently no pharmacotherapy approved for treating methamphetamine dependence," Professor Ezard said. “While further…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.